A Company Built on a Promise
Here for people today and tomorrow
The face(s) of care
The Fresenius Group structure
We are proud to be part of the Fresenius Group with its more than 190,000 employees worldwide. Every day, we use all dedication, expertise, and passion to help advance healthcare opportunities and make a difference in people’s lives everywhere. Together, the Fresenius Group has a combined annual revenue of €22.3 billion with a positive financial forecast for the coming years.
Assisting critically and chronically ill patients with quality solutions for infusion, transfusion, and clinical nutrition.
2023 sales > €8.0 billion
Making an impact as Europe’s leading private hospital operator with HELIOS and Quirónsalud hospitals.
2023 sales > 12.3 billion
Learn more about Fresenius Helios
Fresenius Medical Care
Helping people with chronic kidney failure live their best lives through comprehensive products and services.
Learn more about Fresenius Medical Care
Equipping global hospitals and healthcare facilities with the solutions they need for optimal outcomes.
Learn more about Fresenius Vamed
Consistent, long-term growth
A strong foundation to build on
As a company, we have continued to experience organic growth in all our key market sectors. Our broad industrial base, comprehensive range of system-critical healthcare products and leading market positions in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs. A clear financial strategy, combined with a high-performing team and a new leadership with revised governance ensures a profitable and productive future.